BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/24/2021 9:54:22 AM | Browse: 384 | Download: 760
 |
Received |
|
2021-02-25 17:16 |
|
Peer-Review Started |
|
2021-02-25 17:31 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-05-03 00:26 |
|
Revised |
|
2021-05-06 13:28 |
|
Second Decision |
|
2021-10-08 03:30 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2021-10-11 01:19 |
|
Articles in Press |
|
2021-10-11 01:19 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2021-09-30 13:20 |
|
Typeset the Manuscript |
|
2021-11-19 01:03 |
|
Publish the Manuscript Online |
|
2021-11-24 09:54 |
| ISSN |
1948-5182 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Review |
| Article Title |
Liver involvement in inflammatory bowel disease: What should the clinician know?
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Giuseppe Losurdo, Irene Vita Brescia, Chiara Lillo, Martino Mezzapesa, Michele Barone, Mariabeatrice Principi, Enzo Ierardi, Alfredo Di Leo and Maria Rendina |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Giuseppe Losurdo, MD, Doctor, Section of Gastroenterology, Department of Emergency and Organ Transplantation, University of Bari, Pzza Giulio Cesare, Bari 70124, Italy. giuseppelos@alice.it |
| Key Words |
Inflammatory bowel disease; Liver; Primary sclerosing cholangitis; Viral hepatitis; Immunosuppression; Non-alcoholic fatty liver disease |
| Core Tip |
In the present article, several aspects of liver involvement of inflammatory bowel disease (IBD) have been highlighted. Co-occurrence of primary sclerosing cholangitis is one of the most well-known comorbidities and deserves more attention by the clinician. Liver damage due to drugs used to cure IBD is also a relevant issue. Finally, some emerging topics such as the spread of liver steatosis or the implications of chronic viral hepatitis have been analyzed. |
| Publish Date |
2021-11-24 09:54 |
| Citation |
Losurdo G, Brescia IV, Lillo C, Mezzapesa M, Barone M, Principi M, Ierardi E, Di Leo A, Rendina M. Liver involvement in inflammatory bowel disease: What should the clinician know? World J Hepatol 2021; 13(11): 1534-1551 |
| URL |
https://www.wjgnet.com/1948-5182/full/v13/i11/1534.htm |
| DOI |
https://dx.doi.org/10.4254/wjh.v13.i11.1534 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
